Polymer and nano-technology applications for repair and reconstruction of the central nervous system

Experimental Neurology

Volumn 233, Issue 1, 2012, Pages 126-144

  Cho, Youngnam ^a   Borgens, Richard Ben ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Chitosan; Drug delivery; Nanoparticles; Polyethylene glycol (PEG); Secondary injury; Traumatic spinal cord and brain injury

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACROLEIN; ADENOSINE TRIPHOSPHATE; CHITOSAN; FUSOGEN; GLUTATHIONE; HYDRALAZINE; LIPID HYDROPEROXIDE; MACROGOL; MESOPOROUS SILICA NANOPARTICLE; NANOPARTICLE; POLYMER; REACTIVE OXYGEN METABOLITE; SEALANT; SILICA NANOPARTICLE; SILICON DIOXIDE; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL BEHAVIOR; BEHAVIORAL RECOVERY; BEHAVIORAL SCIENCE; BLOOD BRAIN BARRIER; CELL ASSAY; CELL DAMAGE; CONTROLLED DRUG RELEASE; CUTANEOUS TRUNCI MUSCLE SPINAL REFLEX; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG SCREENING; DYE EXCLUSION TEST; FUNCTIONAL ASSESSMENT; HUMAN; IN VITRO STUDY; MEMBRANE SEALING; NANOBIOTECHNOLOGY; NERVE CELL LESION; NERVE CONDUCTION; NERVE FIBER MEMBRANE; NERVE RECONSTRUCTION; NERVE REGENERATION; NEURAL TISSUE ENGINEERING; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; SPINAL REFLEX; TISSUE ENGINEERING; TRAUMATIC BRAIN INJURY;

ADENOSINE TRIPHOSPHATE; ANIMALS; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM; DRUG DELIVERY SYSTEMS; GLUTATHIONE; HUMANS; MODELS, BIOLOGICAL; NANOTECHNOLOGY; POLYMERS; REACTIVE OXYGEN SPECIES; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; WOUND HEALING;

EID: 84856209675     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.09.028     Document Type: Review

References (146)

1. Abidian M., Kim D., Martin D. Conducting-polymer nanotubes for controlled drug release. Adv. Mater. 2006, 18:405-409.
2. Aznar E., Marcos M.D., Martinez-Manez R., Sancenon F., Soto J., Amoros P., Guillem C. pH- and photo-switched release of guest molecules from mesoporous silica supports. J. Am. Chem. Soc. 2009, 131:6833-6843.
3. Barnett S.C., Riddell J.S. Olfactory ensheathing cells (OECs) and the treatment of CNS injury: advantages and possible caveats. J. Anat. 2004, 204:57-67.
4. Basso D.M., Beattie M.S., Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma. 1995, 12:1-21.
5. Benyamini H., Shulman-Peleg A., Wolfson H.J., Belgorodsky B., Fadeev L., Gozin M. Interaction of C60-fullerene and carboxyfullerene with proteins: docking and binding site alignment. Bioconjug. Chem. 2006, 17:378-386.
6. Berkowitz M., O'Leary P.K., Kruse D.L., Harvey C. Spinal Cord Injury: An Analysis of Medical and Social Costs 1998, Demos Medical Publishing Inc., New York.
7. Blight A.R., Mcginnis M.E., Borgens R.B. Cutaneus trunci muscle reflex of the guinea pig. J. Comp. Neurol. 1990, 296:614-633.
8. Borgens R.B. Restoring Function to the Injured Human Spinal Cord 2001, 1-2. Springer.
9. Borgens, R. B., 2001. Cellular engineering: molecular repair of membranes to rescue cells of the damaged nervous system. Neurosurgery 49, 370-378; discussion 378-379.
10. Borgens R.B., Shi R. Immediate recovery from spinal cord injury through molecular repair of nerve membranes with polyethylene glycol. FASEB J. 2000, 14:27-35.
11. Borgens R.B., Roederer E., Cohen M.J. Enhanced spinal cord regeneration in lamprey by applied electric fields. Science 1981, 213:611-617.
12. Borgens R.B., Shi R., Bohnert D. Behavioral recovery from spinal cord injury following delayed application of polyethylene glycol. J. Exp. Biol. 2002, 205:1-12.
13. Borgens R.B., Bohnert D., Duerstock B., Spomar D., Lee R.C. Subcutaneous tri-block copolymer produces recovery from spinal cord injury. J. Neurosci. Res. 2004, 76:141-154.
14. Boruch A.V., Conners J.J., Pipitone M., Deadwyler G., Storer P.D., Devries G.H., Jones K.J. Neurotrophic and migratory properties of an olfactory ensheathing cell line. GLIA 2001, 33:225-229.
15. Botterhuis N.E., Sun Q., Magusin P.C., Van Santen R.A., Sommerdijk N.A. Hollow silica spheres with an ordered pore structure and their application in controlled release studies. Chemistry 2006, 12:1448-1456.
16. Brannon-Peppas L., Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 2004, 56:1649-1659.
17. Brent J. Current management of ethylene glycol poisoning. Drugs 2001, 61:979-988.
18. Cao L., Su Z., Zhou Q., Lv B., Liu X., Jiao L., Li Z., Zhu Y., Huang Z., Huang A., He C. Glial cell line-derived neurotrophic factor promotes olfactory ensheathing cells migration. GLIA 2006, 54:536-544.
19. Cho Y., Borgens R.B. The preparation of polypyrrole surfaces in the presence of mesoporous silica nanoparticles and their biomedical applications. Nanotechnology 2010, 21:205102.
20. Cho Y., Borgens R.B. The effect of an electrically conductive carbon nanotube/collagen composite on neurite outgrowth of PC12 cells. J. Biomed. Mater. Res. A 2010, 95A:510-517.
21. Cho Y., Shi R., Borgens R., Ivanisevic A. Repairing the damaged spinal cord and brain with nanomedicine. Small 2008.
22. Cho Y., Shi R., Borgens R.B., Ivanisevic A. Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death. Nanomedicine 2008, 3:507-519.
23. Cho Y., Shi R., Ivanisevic A., Borgens R.B. The functionalized mesoporous silica nanoparticles (MSNs) based drug delivery system to rescue acrolein-mediated cell death. Nanomedicine 2008, 3:507-519.
24. Cho Y., Shi R., Ben Borgens R. Chitosan nanoparticle-based neuronal membrane sealing and neuroprotection following acrolein-induced cell injury. J. Biol. Eng. 2010, 4:2.
25. Cho Y., Shi R., Borgens R.B. Chitosan nanoparticle-based neuronal membrane sealing and neuroprotection following acrolein-induced cell injury. J. Bionic Eng. 2010, 29:2.
26. Cho Y., Shi R., Borgens R.B. Chitosan produces potent neuroprotection and physiological recovery following traumatic spinal cord injury. J. Exp. Biol. 2010, 213:1513-1520.
27. Cho Y., Shi R., Ivanisevic A., Borgens R.B. Functional silica nanoparticle-mediated neuronal membrane sealing following traumatic spinal cord injury. J. Neurosci. Res. 2010, 88:1433-1444.
28. Cho Y., Shi R., Ivanisevic A., Borgens R.B. A mesoporous silica nanosphere-based drug delivery system using an electrically conducting polymer. Nanotechnology 2010, 20:275102-275114.
29. Costantino L., Gandolfi F., Tosi G., Rivasi F., Vandelli M.A., Forni F. Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier. J. Controlled Release 2005, 108:84-96.
30. Davidson R.L., Gerald P.S. Improved techniques for the induction of mammalian cell hybridization by polyethylene glycol. Somat. Cell Genet. 1976, 2:165-176.
31. Davidson R.L., O'Malley K.A., Wheeler T.B. Induction of mammalian somatic cell hybridization by polyethylene glycol. Somat. Cell Genet. 1976, 2:271-280.
32. Devivo M.J., Whiteneck G.C., Charles J.E.D. The Economic Impact of Spinal Cord Injury 1995, Aspen Publications.
33. Ditor D.S., John S.M., Roy J., Marx J.C., Kittmer C., Weaver L.C. Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat. J. Neurosci. Res. 2007, 85:1458-1467.
34. Donaldson J., Shi R., Borgens R. Polyethylene glycol rapidly restores physiological functions in damaged sciatic nerves of guinea pigs. Neurosurgery 2002, 50:147-156.
35. Dugan L.L., Turetsky D.M., Du C., Lobner D., Wheeler M., Almli C.R., Shen C.K.-F., Luh T.-Y., Choi D.W., Lin T.S. Carboxyfullerenes as neuroprotective agents. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:9434-9439.
36. Dugana L.L., Lovetta E.G., Quicka K.L., Lothariusb J., Linc T.T., O'Malley K.L. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat. Disord. 2001, 7:243-246.
37. Duncan R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. 2003, 2:347-360.
38. Emerich D.F., Thanos C.G. The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis. Biomol. Eng. 2006, 23:171-184.
39. English A.W., Schwartz G., Meador W., Sabatier M.J., Mulligan A. Electrical stimulation promotes peripheral axon regeneration by enhanced neuronal neurotrophin signaling. Dev. Neurobiol. 2007, 67:158-172.
40. Fang N., Chan V. Chitosan-induced restructuration of a mica-supported phospholipid bilayer: an atomic force microscopy study. Biomacromolecules 2003, 4:1596-1604.
41. Fang N., Chan V., Mao H.Q., Leong K.W. Interactions of phospholipid bilayer with chitosan: effect of molecular weight and pH. Biomacromolecules 2001, 2:1161-1168.
42. Faraji A.H., Wipf P. Nanoparticles in cellular drug delivery. Bioorg. Med. Chem. 2009, 17:2950-2962.
43. Gan Q., Wang T. Chitosan nanoparticle as protein delivery carrier-systematic examination of fabrication conditions for efficient loading and release. Colloids Surf. B Biointerfaces 2007, 59:24-34.
44. Goldman S. Stem and progenitor cell-based therapy of the human central nervous system. Nat. Biotechnol. 2005, 7:862-871.
45. Hamann K., Shi R. Acrolein scavenging: a potential novel mechanism of attenuating oxidative stress following spinal cord injury. J. Neurochem. 2009, 111:1348-1356.
46. Harrison B., Atala A. Carbon nanotube applications for tissue engineering. Biomaterials 2007, 28:344-353.
47. Hoet P., Bruske-Hohlfeld I., Salata O. Nanoparticles - known and unknown health risks. J. Nanobiotechnol. 2004, 2:12.
48. Hu H., Ni Y., Montana V., Haddon R.C., Parpura V. Chemically functionalized carbon nanotubes as substrates for neuronal growth. Nano Lett. 2004, 4:507-511.
49. Illum L., Farraj N.F., Davis S.S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 1994, 11:1186-1189.
50. Jain K.K. Neuroprotection in spinal cord injury. The Handbook of Neuroprotection 2011, 255-280. Humana Press, New York, NY.
51. Jain K.K. Neuroprotection in traumatic brain injury 2011, The Handbook of Neuroprotection. Humana Press, New York, NY, pp. 217-253.
52. Jain K.K. Regenerative therapy for central nervous system trauma. Regenerative Medicine 2011, 605-625. Springer. G. Steinhoff (Ed.).
53. Janes K.A., Fresneau M.P., Marazuela A., Fabra A., Alonso M.J. Chitosan nanoparticles as delivery systems for doxorubicin. J. Control Release 2001, 73:255-267.
54. Jin S., Ye K. Nanoparticle-mediated drug delivery and gene therapy. Biotechnol. Prog. 2007, 23:32-41.
55. Keefer E.W., Botterman B.R., Romero M.I., Rossi A.F., Gross G.W. Carbon nanotube coating improves neuronal recordings. Nat. Nanotechnol. 2008, 3:434-438.
56. Kim J., Lee J.E., Lee J., Yu J.H., Kim B.C., An K., Hwang Y., Shin C.H., Park J.G., Hyeon T. Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. J. Am. Chem. Soc. 2006, 128:688-689.
57. Koob A.O., Borgens R.B. Polyethylene glycol treatment after traumatic brain injury reduces beta-amyloid precursor protein accumulation in degenerating axons. J. Neurosci. Res. 2006, 83:1558-1563.
58. Koob A.O., Duerstock B.S., Babbs C.F., Sun Y., Borgens R.B. Intravenous polyethylene glycol inhibits the loss of cerebral cells after brain injury. J. Neurotrauma. 2005, 22:1092-1111.
59. Koob A.O., Cirillo J., Babbs C.F. A novel open field activity detector to determine spatial and temporal movement of laboratory animals after injury and disease. J. Neurosci. Methods 2006, 157:330-336.
60. Kwon B.K., Roy J., Lee J.H., Okon E., Zhang H., Marx J.C., Kindy M.S. Magnesium chloride in a polyethylene glycol formulation as a neuroprotective therapy for acute spinal cord injury: preclinical refinement and optimization. J. Neurotrauma 2009, 26:1379-1393.
61. Lai C.Y., Trewyn B.G., Jeftinija D.M., Jeftinija K., Xu S., Jeftinija S., Lin V.S. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J. Am. Chem. Soc. 2003, 125:4451-4459.
62. Laverty P.H., Leskovar A., Breur G.J., Coates J.R., Bergman R.L., Widmer W.R., Toombs J.P., Shapiro S., Borgens R.B. A preliminary study of intravenous surfactants in paraplegic dogs: polymer therapy in canine clinical SCI. J. Neurotrauma 2004, 21:1767-1777.
63. Lee R.C., River L.P., Pan F.S., Wollman R.S. Surfactant-induced sealing of electrpermeabilized skeletal muscle membranes in vitro. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:4524-4528.
64. Lewitt P.A., Rezai A.R., Leehey M.A., Ojemann S.G., Flaherty A.W., Eskandar E.N., Kostyk S.K., Thomas K., Sarkar A., Siddiqui M.S., Tatter S.B., Schwalb J.M., Poston K.L., Henderson J.M., Kurlan R.M., Richard I.H., Van Meter L., Sapan C.V., During M.J., Kaplitt M.G., Feigin A. AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol. 2011, 10:309-319.
65. Li C., Liu H., Sun Y., Wang H., Guo F., Rao S., Deng J., Zhang Y., Miao Y., Guo C., Meng J., Chen X., Li L., Li D., Xu H., Li B., Jiang C. PAMAM nanoparticles promote acute lung injury by inducing autophagic cell death through the Akt-TSC2-mTOR signaling pathway. J. Mol. Cell Biol. 2009, 1:37-45.
66. Liao H., Duka T., Teng F.Y., Sun K., Bu W.Y., Ahmed S., Tang B.L., Xiao Z.C. Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells. J. Neurochem. 2004, 90:1156-1162.
67. Lin Y.-S., Tsai C.-P., Huang H.-Y., Kuo C.-T., Hung Y., Huang D.-M., Chen Y.-C., Mou C.-Y. Well-ordered mesoporous silica nanoparticles as cell markers. Chem. Mater. 2005, 17:4570-4573.
68. Liu Y., Wang H. Nanomedicine: nanotechnology tackles tumours. Nat. Nanotechnol. 2007, 2:20-21.
69. Liu B.P., Fournier A., GrandPre' T., Strittmatter S.M. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 2002, 297:1190-1193.
70. Liu Y., Miyoshi H., Nakamura M. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int. J. Cancer 2007, 120:2527-2537.
71. Liu-Snyder P., Borgens R.B., Shi R. Hydralazine rescues PC12 cells from acrolein-mediated death. J. Neurosci. Res. 2006, 84:219-227.
72. Liu-Snyder P., Mcnally H., Shi R., Borgens R.B. Acrolein-mediated mechanisms of neuronal death. J. Neurosci. Res. 2006, 84:209-218.
73. Liu-Snyder P., Logan M.P., Shi R., Smith D.T., Borgens R.B. Neuroprotection from secondary injury by polyethylene glycol requires its internalization. J. Exp. Biol. 2007, 210:1455-1462.
74. Lu P., Yang H., Jones L.L., Filbin M.T., Tuszynski M.H. Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J. Neurosci. 2004, 24:6402-6409.
75. Luo J., Shi R. Diffusive oxidative stress following acute spinal cord injury in guinea pigs and its inhibition by polyethylene glycol. Neurosci. Lett. 2004, 359:167-170.
76. Luo J., Shi R. Polyethylene glycol inhibits apoptotic cell death following traumatic spinal cord injury. Brain Res. 2007, 1155:10-16.
77. Luo J., Borgens R.B., Shi R. Polyethylene glycol immediately repairs neuronal membranes and inhibits free radical production after acute spinal cord injury. J. Neurochem. 2002, 83:471-480.
78. Luo J., Borgens R., Shi R. Polyethylene glycol improves function and reduces oxidative stress in synaptosomal preparations following spinal cord injury. J. Neurotrauma 2004, 21:994-1007.
79. Lykissas M.G., Batistatou A.K., Charalabopoulos K.A., Beris A.E. The role of neurotrophins in axonal growth, guidance, and regeneration. Curr. Neurovasc. Res. 2007, 4:143-151.
80. Ma Y.H., Zhang Y., Cao L., Su J.C., Wang Z.W., Xu A.B., Zhang S.C. Effect of neurotrophin-3 genetically modified olfactory ensheathing cells transplantation on spinal cord injury. Cell Transplant. 2010, 19:167-177.
81. Madihally S.V., Matthew H.W. Porous chitosan scaffolds for tissue engineering. Biomaterials 1999, 20:1133-1142.
82. Marmarou A. Traumatic brain edema: an overview. Acta Neurochir. Suppl. (Wien) 1994, 60:421-424.
83. Marmarou A., Foda M.A., Van Den Brink W., Campbell J., Kita H., Demetriadou K. A new model of diffuse brain injury in rats. Part I: pathophysiology and biomechanics. J. Neurosurg. 1994, 80:291-300.
84. Marmarou A., Hochwald G., Nakamura T., Tanaka K., Weaver J., Dunbar J. Brain edema resolution by CSF pathways and brain vasculature in cats. Am. J. Physiol. 1994, 267:H514-H520.
85. Mcnally H.A., Borgens R.B. Three-dimensional imaging of living and dying neurons with atomic force microscopy. J. Neurocytol. 2004, 33:251-258.
86. Merchant F.A., Holmes W.H., Capelli-Schellpfeffer B.S., Lee R.C., Toner M. Poloxamer 188 enhances functional recovery of lethally heat-shocked fibroblasts. J. Surg. Res. 1998, 74:131-140.
87. Meyers D.B., Nadkarni M.V., Zopf L.C. The absorption and penetration of therapeutic agents from a Carbowax vehicle. J. Am. Pharm. Assoc. 2006, 38:231-234.
88. Munoz B., Ramila A., Perez-Pariente J., Diaz I., Vallet-Regi M. MCM-41 organic modification as drug delivery rate regulator. Chem. Mater. 2003, 15:500-503.
89. Nakajima N., Ikada Y. Fusogenic activity of various water-soluble polymers. J. Biomater. Sci. Polym. Ed 1994, 6:751-759.
90. Niederöst B., Oertle T., Fritsche J., Mckinney R.A., Bandtlow C.E. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J. Neurosci. 2002, 22:10368-10376.
91. Novikov L., Novikova L., Kellerth J.-O. Brain-derived neurotrophic factor promotes axonal regeneration and long-term survival of adult rat spinal motoneurons in vivo. Neuroscience 1997, 79:765-774.
92. O'Lague P.H., Huttner S.L. Physiological and morphological studies of rat pheochromocytoma cells (PC12) chemically fused and grown in culture. Proc. Natl. Acad. Sci. U. S. A. 1980, 77:1701-1705.
93. Pardridge W.M. Targeting neurotherapeutic agents through the blood-brain barrier. Arch. Neurol. 2002, 59:35-40.
94. Povlishock J.T., Marmarou A., Mcintosh T., Trojanowski J.Q., Moroi J. Impact acceleration injury in the rat: evidence for focal axolemmal change and related neurofilament sidearm alteration. J. Neuropathol. Exp. Neurol. 1997, 56:347-359.
95. Qhobosheane M., Santra S., Zhang P., Tan W. Biochemically functionalized silica nanoparticles. Analyst 2001, 126:1274-1278.
96. Reddy M.K., Labhasetwar V. Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. FASEB 2009, 23:1384-1395.
97. Rhyner M.N., Smith A.M., Gao X., Mao H., Yang L., Nie S. Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging. Nanomedicine (Lond) 2006, 1:209-217.
98. Roy K., Mao H.Q., Huang S.K., Leong K.W. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 1999, 5:387-391.
99. Ryman-Rasmussen J.P., Cesta M.F., Brody A.R., Shipley-Phillips J.K., Everitt J.I., Tewksbury E.W., Moss O.R., Wong B.A., Dodd D.E., Andersen M.E., Bonner J.C. Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat. Nanotechnol. 2009, 4:747-751.
100. Ryman-Rasmussen J.P., Tewksbury E.W., Moss O.R., Cesta M.F., Wong B.A., Bonner J.C. Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma. Am. J. Respir. Cell Mol. Biol. 2009, 40:349-358.
101. Sakamoto Y., Nakae D., Fukumori N., Tayama K., Maekawa A., Imai K., Hirose A., Nishimura T., Ohashi N., Ogata A. Induction of mesothelioma by a single intrascrotal administration of multi-wall carbon nanotube in intact male Fischer 344 rats. J. Toxicol. Sci. 2009, 34:65-76.
102. Sapolsky R.M. Neuroprotective gene therapy against acute neurological insults. Nat. Rev. Neurosci. 2003, 4:61-69.
103. Schmidt C., Leach J. Neural tissue engineering: strategies for repair and regeneration. Annu. Rev. Biomed. Eng. 2003, 5:293-347.
104. Schwab M.E. Repairing the injured spinal cord. Science 2002, 295:1029-1031.
105. Seidler C. Nanotechnology: danger in tiny particles. Bloomberg Businessweek 2009, Bloomberg L.P, Europe.
106. Serbest G., Horwitz J., Jost M., Barbee K. Mechanisms of cell death and neuroprotection by poloxamer 188 after mechanical trauma. FASEB J. 2006, 20:308-310.
107. Service R.F. Materials and biology: nanotechnology takes aim at cancer. Science 2005, 310:1132-1134.
108. Shapiro S., Borgens R., Pascuzzi R., Roos K., Groff M., Purvines S., Rodgers R.B., Hagy S., Nelson P. Oscillating field stimulation for complete spinal cord injury in humans: a phase 1 trial. J. Neurosurg. Spine 2005, 2:3-10.
109. Shi Y., Kim S., Huff T.B., Borgens R.B., Park K., Shi R., Cheng J.-X. Effective repair of traumatically injured spinal cord by nanoscale block copolymer micelles. Nat. Nanotechnol. 2009, 5:80-87.
110. Silva G.A. Neuroscience nanotechnology: progress, opportunities and challenges. Nat. Rev. Neurosci. 2006, 7:65-74.
111. Silva G.A. Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier. Surg. Neurol. 2007, 67:113-116.
112. Silva G. Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS. BMC Neurosci. 2008, 9:S4.
113. Silva G.A., Czeisler C., Niece K.L., Beniash E., Kessler J.A., Stupp S.I. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 2004, 303:1352-1355.
114. Silver J., Miller H. Regeneration beyond the glial scar. Nature 2004, 5:146-156.
115. Skirtach A., Kreft O. Stimuli-Sensitive Nanotechnology for Drug Delivery 2009, Springer.
116. Slowing I.I., Trewyn B.G., Lin V.S. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J. Am. Chem. Soc. 2007, 129:8845-8849.
117. Spencer T., Domeniconi M., Cao Z., Filbin M.T. New roles for old proteins in adult CNS axonal regeneration. Curr. Opin. Neurobiol. 2003, 13:133-139.
118. Stieglitz T. Neural prostheses in clinical practice: biomedical microsystems in neurological rehabilitation. Acta Neurochir. Suppl. 2007, 97:411-418.
119. Stöber W., Fink A., Bohn E. Controlled growth of monodisperse silica spheres in the micron size range. J. Colloid Interface Sci. 1968, 26:62-69.
120. Tenenbaum L., Chtarto A., Lehtonen E., Blum D., Baekelandt V., Velu T., Brotchi J., Levivier M. Neuroprotective gene therapy for Parkinson's disease. Curr. Gene Ther. 2002, 4:451-483.
121. Theriault E., Diamond J. Intrinsic organization of the rat cutaneus trunci motor nucleus. J. Neurophysiol. 1988, 60:463-477.
122. Theriault E., Diamond J. Nociceptive cutaneous stimuli evoke localized contractions in a skeletal muscle. J. Neurophysiol. 1988, 60:446-462.
123. Thompson B.C., Moulton S.E., Gilmore K.J., Higgins M.J., Whitten P.G., Wallace G.G. Carbon nanotube biogels. Carbon 2009, 47:1282-1291.
124. Thompson B.C., Chen J., Moulton S.E., Wallace G.G. Nanostructured aligned CNT platforms enhance the controlled release of a neurotrophic protein from polypyrrole. Nanoscale 2010, 2:499-501.
125. Thuret S., Moon L.D., Gage F.H. Therapeutic interventions after spinal cord injury. Nat. Rev. Neurosci. 2006, 7:628-643.
126. Thurman D.J., Alverson C., Dunn K.A., Guerrero J., Sniezek J.E. Traumatic brain injury in the United States: a public health perspective. J. Head Trauma Rehabil. 1999, 14:602-615.
127. Timmer, J., 2008. Carbon nanofibers may mimic asbestos?and not in a good way. ars. http://arstechnica.com/old/content/2008/05/carbon-nanofibers-may-mimic-asbestosand-not-in-a-good-way.ars.
128. Tiwari S.B., Amiji M.M. A review of nanocarrier-based CNS delivery systems. Curr. Drug Deliv. 2006, 3:219-232.
129. Torney F., Trewyn B.G., Lin V.S., Wang K. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat. Nanotechnol. 2007, 2:295-300.
130. Tysseling-Mattiace V.M., Sahni V., Niece K.L., Birch D., Czeisler C., Fehlings M.G., Stupp S.I., Kessler J.A. Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury. J. Neurosci. 2008, 28:3814-3823.
131. Tysseling-Mattiace V.M., Sahni V., Pashuck T., Birch D., Hebert A., Czeisler C., Stupp S.I., Kessler J.A. Self-assembling peptide amphiphile promotes plasticity of serotonergic fibers following spinal cord injury. J. Neurosci. Res. 2010, 88:3161-3170.
132. Ueno H., Yamada H., Tanaka I., Kaba N., Matsuura M., Okumura M., Kadosawa T., Fujinaga T. Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs. Biomaterials 1999, 20:1407-1414.
133. Wallace G., Spinks G. Conducting polymers-bridging the bionic interface. Soft Matter 2007, 3:665-671.
134. Walters B.C. Oscillating field stimulation in the treatment of spinal cord injury. PM R 2010, 2:S286-S291.
135. Wang Y., Caruso F. Mesoporous silica spheres as supports for enzyme immobilization and encapsulation. Chem. Mater. 2005, 17:953-961.
136. Wang X., Gu X., Yuan C., Chen S., Zhang P., Zhang T., Yao J., Chen F., Chen G. Electrically controlled drug delivery from biotin-doped conductive polypyrrole. J. Biomed. Mater. Res. A. 2004, 1:411-422.
137. Wang L., Wang K., Santra S., Zhao X., Hilliard L.R., Smith J.E., Wu Y., Tan W. Watching silica nanoparticles glow in the biological world. Anal. Chem. 2006, 647-654.
138. Weissman I.L. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 2000, 287:1442-1446.
139. Weissman I.L., Anderson D.J., Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu. Rev. Cell Dev. Biol. 2001, 17:387-403.
140. Wewetzer K., Verdú E., Angelov D.N., Navarro X. Olfactory ensheathing glia and Schwann cells: two of a kind?. Cell Tissue Res. 2002, 309:337-345.
141. Willerth S., Sakiyama-Elbert S. Approaches to neural tissue engineering using scaffolds for drug delivery. Adv. Drug Deliv. Rev. 2007, 59:325-338.
142. Working P., Newman M., Johnson J., Cornacoff J. Safety of polyethylene glycol and polyethylene glycol derivatives. Poly (ethylene glycol) Chemistry and Biological Applications 1997, 45-47. American Chemistry Society, Washington D.C. J. Milton Harris, S. Zalipsky (Eds.).
143. Wu C., Hong J., Guo X., Huang C., Lai J., Zheng J., Chen J., Mu X., Zhao Y. Fluorescent core-shell silica nanoparticles as tunable precursors: towards encoding and multifunctional nano-probes. Chem. Commun. (Camb) 2008, 750-752.
144. Xu G., Yong K.-T., Roy I., Mahajan S.D., Ding H., Schwartz S.A., Prasad P.N. Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood brain barrier. Bioconjug. Chem. 2008, 19:1179-1185.
145. Yu A., Wang Y., Barlow E., Caruso F. Mesoporous silica particles as templates for preparing enzyme-loaded biocompatible microcapsules. Adv. Mater. 2005, 17:1737-1741.
146. Zuo Y.Y., Alolabi H., Shafiei A., Kang N., Policova Z., Cox P.N., Acosta E., Hair M.L., Neumann A.W. Chitosan enhances the in vitro surface activity of dilute lung surfactant preparations and resists albumin-induced inactivation. Pediatr. Res. 2006, 60:125-130.